Marfo K - Search Results

1

Pretransplant immunologic risk assessment of kidney transplant recipients with donor-specific anti-human leukocyte antigen antibodies.

Marfo K, Ajaimy M, Colovai A, Kayler L, Greenstein S, Lubetzky M, Gupta A, Kamal L, de Boccardo G, Masiakos P, Kinkhabwala M, Akalin E. Marfo K, et al. Transplantation. 2014 Nov 27;98(10):1082-8. doi: 10.1097/TP.0000000000000191. Transplantation. 2014. PMID: 24873780

2

Lack of effect in desensitization with intravenous immunoglobulin and rituximab in highly sensitized patients.

Marfo K, Ling M, Bao Y, Calder B, Ye B, Hayde N, Greenstein S, Chapochnick-Friedman J, Glicklich D, de Boccardo G, Kinkhabwala M, Akalin E. Marfo K, et al. Transplantation. 2012 Aug 27;94(4):345-51. doi: 10.1097/TP.0b013e3182590d2e. Transplantation. 2012. PMID: 22820699

3

Pretransplant anti-HLA-Cw and anti-HLA-DP antibodies in sensitized patients.

Ling M, Marfo K, Masiakos P, Aljanabi A, Lindower J, Glicklich D, de Boccardo G, Greenstein S, Chapochnick-Friedmann J, Kayler L, Kinkhabwala M, Akalin E. Ling M, et al. Among authors: marfo k. Hum Immunol. 2012 Sep;73(9):879-83. doi: 10.1016/j.humimm.2012.07.320. Epub 2012 Jul 25. Hum Immunol. 2012. PMID: 22841893

4

Campath induction in HCV and HCV/HIV-seropositive kidney transplant recipients.

Vivanco M, Friedmann P, Xia Y, Klair T, Marfo K, de Boccardo G, Greenstein S, Chapochnick-Friedmann J, Kinkhabwala M, Ajaimy M, Lubetzky ML, Akalin E, Kayler LK. Vivanco M, et al. Among authors: marfo k. Transpl Int. 2013 Oct;26(10):1016-26. doi: 10.1111/tri.12167. Epub 2013 Aug 16. Transpl Int. 2013. PMID: 23947744 Free article.

5

Genomics of BK viremia in kidney transplant recipients.

Lubetzky M, Bao Y, O Broin P, Marfo K, Ajaimy M, Aljanabi A, de Boccardo G, Golden A, Akalin E. Lubetzky M, et al. Among authors: marfo k. Transplantation. 2014 Feb 27;97(4):451-6. doi: 10.1097/01.TP.0000437432.35227.3e. Transplantation. 2014. PMID: 24310299

6

Antiretroviral and immunosuppressive drug-drug interactions in human immunodeficiency virus-infected liver and kidney transplant recipients.

Marfo K, Greenstein S. Marfo K, et al. Transplant Proc. 2009 Nov;41(9):3796-9. doi: 10.1016/j.transproceed.2009.06.186. Transplant Proc. 2009. PMID: 19917390

7

Desensitization protocols and their outcome.

Marfo K, Lu A, Ling M, Akalin E. Marfo K, et al. Clin J Am Soc Nephrol. 2011 Apr;6(4):922-36. doi: 10.2215/CJN.08140910. Epub 2011 Mar 24. Clin J Am Soc Nephrol. 2011. PMID: 21441131 Review.

8

Clinical and economic analysis of short-course versus standard-course antithymocyte globulin (rabbit) induction therapy in deceased-donor renal transplant recipients.

Marfo K, Akalin E, Wang C, Lu A. Marfo K, et al. Am J Health Syst Pharm. 2011 Dec 1;68(23):2276-82. doi: 10.2146/ajhp110120. Am J Health Syst Pharm. 2011. PMID: 22095818

9

Postexposure prophylaxis of H1N1 with oseltamivir in a newly transplanted kidney recipient receiving intense immunosuppressive therapy.

Marfo K, Chapochnick-Friedmann J, Akalin E, Lu A. Marfo K, et al. Transplant Proc. 2009 Dec;41(10):4411-3. doi: 10.1016/j.transproceed.2009.09.052. Transplant Proc. 2009. PMID: 20005410

10

Reply to "Defining the benefits of desensitization therapy".

Marfo K, Akalin E. Marfo K, et al. Transplantation. 2013 Mar 27;95(6):e33-4. doi: 10.1097/TP.0b013e3182846013. Transplantation. 2013. PMID: 23507653 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters